Remove 2006 Remove Access Remove Programs
article thumbnail

Cannabis laws in Belgium

The Cannigma

The country has a limited medical cannabis program that recognizes Sativex and CBD. There are a number of cannabis social clubs throughout the country, some of which date back to 2006. Belgium medical cannabis program. Medical patients can access certain types of CBD products from pharmacies and grow their own plants.

Law 98
article thumbnail

Metrc Grab Rhode Island Contract

Cannabis Law Report

And this same tracking information is accessible to state regulators, providing the ultimate transparency to ensure regulatory compliance, help combat the illicit market, and safeguard the health and well-being of Rhode Island medical marijuana patients. “As Metrc now holds exclusive government contracts in every region of the U.S

Data 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Policy Analysis Paper: Medicinal cannabis and driving: the intersection of health and road safety policy

Cannabis Law Report

Recent shifting attitudes towards the medical use of cannabis has seen legal access pathways established in many jurisdictions in North America, Europe and Australasia. Others who need to drive are excluded from accessing a needed medication and associated therapeutic benefit. Background. Conclusion. S0955395921002127-main.

Policy 51
article thumbnail

Article: UC Berkeley Center for the Science of Psychedelics – Psychedelics and the Law

Cannabis Law Report

As more and more scientific research supports the therapeutic and medicinal potential of psychedelics, states and cities have begun to make these substances more accessible. And in 2019, Usona Institute was granted BTD to develop a psilocybin program to treat major depressive disorder. Where Laws Are Changing.

Law 74
article thumbnail

Australia – Policy Analysis: Medicinal cannabis and driving: the intersection of health and road safety policy – “there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications”

Cannabis Law Report

We conclude that in medical-only access models there is little evidence to justify the differential treatment of medicinal cannabis patients, compared with those taking other prescription medications with potentially impairing effects. Faculty of Science, School of Psychology, The University of Sydney, Sydney, NSW 2006, Australia.

article thumbnail

MAPS Is 36 Years Old – Doblin Provides Precis Timeline of the Organization

Cannabis Law Report

The MDMA Therapy Training Program was created to train the next generation of psychedelic therapists. The FDA agreed to an expanded access program for MDMA-assisted therapy for PTSD, MAPS donors raised $30 million for psychedelic research during the Capstone Campaign, and we announced the positive result from our first Phase 3 trial.

article thumbnail

Harborside Inc. Announces Increased Interest in Haight-Ashbury Dispensary

Cannabis Law Report

Founded in California in 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States. Additional information regarding Harborside is available under Harborside’s SEDAR profile at www.sedar.com.